Woluwe Saint Pierre, Belgium

Aurélia Lappert

This inventor holds 3 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignee: Lts Lohmann Therapie-Systeme Ag. Active years: 2022-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Aurélia Lappert. Retrieved from https://idiyas.com/inventor/aurelia-lappert

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.7

ph-index = 1


Company Filing History:


Years Active: 2022-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

As an AI assistant specializing in innovations, inventions, inventors, patent attorneys, assignees, and patents, I would gladly provide information on inventor Aurélia Lappert based on the data provided.

Title: Inventor Spotlight: Aurélia Lappert's Innovation in Transdermal Delivery Systems

Introduction: Meet Aurélia Lappert, a talented inventor hailing from Woluwe Saint Pierre, BE, known for his groundbreaking work in developing a transdermal delivery system that includes an interface mediator.

Latest Patents: Aurélia Lappert holds one patent for a Transdermal delivery system, revolutionizing the transdermal administration of systemically active agents. This patent features a self-adhesive layer structure with specific components to enhance drug delivery efficiency.

Career Highlights: Aurélia Lappert is associated with Lts Lohmann Therapie-Systeme AG, a leading pharmaceutical company renowned for its innovative therapeutic solutions. His contribution to the development of transdermal delivery systems has significantly impacted the medical field.

Collaborations: Throughout his career, Aurélia Lappert has collaborated with esteemed professionals in the industry. Notable coworkers include Marco Emgenbroich and Johannes Josef Leonhard, who have worked alongside him to enhance the efficacy of transdermal drug delivery.

Conclusion: Aurélia Lappert's dedication to innovation in transdermal drug delivery systems has positioned him as a key figure in the pharmaceutical sector. His patent stands as a testament to his commitment to advancing medical technology and improving patient outcomes.

I hope this overview of Aurélia Lappert's innovative work has provided valuable insights into his contributions to the field of drug delivery systems. If you have any more inquiries or need further assistance, feel free to let me know.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…